Debilitating Muscular Weakness and Steroid Therapy
- 30 June 1961
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 5 (1), 60-67
- https://doi.org/10.1001/archneur.1961.00450130062008
Abstract
Introduction Muscle weakness is now recognized as an uncommon though serious complication of steroid therapy, with most of the synthetic adrenal corticosteroids in clinical use. Although biopsies have shown structural changes in some of the reported cases of steroid-induced weakness,1-4 this case provides the only example known to us in which necropsy afforded the opportunity for extensive study of multiple muscle groups. The case described in this paper is that of an older man who developed disabling muscular weakness while receiving a variety of steroids for a refractory anemia. Report of Case This patient was a 65-year-old white male accountant who entered the New York Hospital for his fourth and terminal admission on June 26, 1959, because of disabling weakness and general debility. In 1953 the patient developed an unexplained anemia for which 15 blood transfusions were given over a period of 4 years. Splenomegaly was first notedKeywords
This publication has 7 references indexed in Scilit:
- Excitability in experimental myopathyNeurology, 1958
- Vacuolar Myopathy in Systemic Lupus ErythematosusAmerican Journal of Clinical Pathology, 1958
- NECROSIS AND REGENERATION OF SKELETAL MUSCLES IN CORTISONE-TREATED RABBITS1956
- PATHOLOGIC CHANGES INDUCED IN GUINEA-PIGS BY ADMINISTRATION OF DIETS DEFICIENT IN THE ANTI-STIFFNESS FACTOR1950
- POTASSIUM DEFICIENCY SYNDROME IN THE RAT AND THE DOG - A DESCRIPTION OF THE MUSCLE CHANGES IN THE POTASSIUM-DEPLETED DOG1950
- Creatinine, Potassium, and Virus Content of the Muscles Following Infection with the "Coxsackie Virus."Experimental Biology and Medicine, 1949
- Lesions of Chronic Thiamine Deficiency in MiceJNCI Journal of the National Cancer Institute, 1947